Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Legend Biotech ( (LEGN) ) has provided an update.
On October 6, 2025, Legend Biotech USA Inc., a subsidiary of Legend Biotech Corporation, entered into a Component and Product Supply Agreement with Janssen Pharmaceuticals, Inc. This agreement, which supersedes a previous interim agreement from February 2022, involves the manufacturing and supply of ciltacabtagene autoleucel (cilta-cel) for clinical and commercial use globally, excluding Greater China. The agreement outlines the shared costs and responsibilities between Legend Biotech and Janssen, including the supply of raw materials and the handling of production costs. This strategic partnership is expected to enhance Legend Biotech’s operational capabilities and strengthen its position in the global biotechnology market.
The most recent analyst rating on (LEGN) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Legend Biotech stock, see the LEGN Stock Forecast page.
Spark’s Take on LEGN Stock
According to Spark, TipRanks’ AI Analyst, LEGN is a Neutral.
Legend Biotech’s overall stock score is driven by its financial performance challenges, including ongoing losses and cash flow issues. Despite positive sentiment from the earnings call and strategic growth initiatives, the stock’s bearish technical indicators and negative valuation metrics weigh heavily on its score. The company’s future prospects hinge on achieving operational efficiency and profitability.
To see Spark’s full report on LEGN stock, click here.
More about Legend Biotech
Legend Biotech Corporation is a prominent player in the biotechnology industry, focusing on the development and commercialization of innovative cell therapies. The company is known for its work in the field of oncology, particularly in the manufacturing and supply of CAR-T cell therapies.
Average Trading Volume: 1,209,623
Technical Sentiment Signal: Sell
Current Market Cap: $5.8B
Find detailed analytics on LEGN stock on TipRanks’ Stock Analysis page.